Preparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomes

International Journal of Pharmaceutics

Volumn 384, Issue 1-2, 2010, Pages 140-147

  Du, Bin ^a   Li, Ying ^a   Li, Xiaotian ^a   A, Youmei ^a   Chen, Chengqun ^a   Zhang, Zhenzhong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

2 Methoxyestradiol; Liposomes; Passive target; Tissue distribution

Indexed keywords

2 METHOXYESTRADIOL; CHOLESTEROL; LETROZOLE; LIPOSOME; NANOPARTICLE; PHOSPHATIDYLCHOLINE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DESIGN; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG TISSUE LEVEL; FEMALE; FIRST PASS EFFECT; FREEZE DRYING; GEL CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INJURY SEVERITY; LUNG INJURY; MALE; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; DRUG EVALUATION, PRECLINICAL; ESTRADIOL; FEMALE; LIPOSOMES; LUNG; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 70649097322     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.045     Document Type: Article

References (38)

1. Anchalee A.A., and Pardeep K.G. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int. J. Pharm. 351 (2008) 282-288
2. Attalla H., Makela T.P., Adlercreutz H., and Andersson L.C. 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem. Biophys. Res. Commun. 228 (1996) 467-473
3. Attalla H., Westberg J.A., Andersson L.C., Adlercreutz H., and Makela T.P. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation. Biochem. Biophys. Res. Commun. 247 (1998) 616-619
4. Avgoustakis K., Beletsi A., and Panagi Z. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 79 (2002) 123-135
5. Barchiesi F., Jackson E.K., Fingerle J., Gillespie D.G., Odermatt B., and Dubey R.K. 2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. Circ. Res. 99 (2006) 266-274
6. Basu A., Castle V.P., Bouziane M., Bhalla K., and Haldar S. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res. 66 (2006) 4309-4318
7. Batzri S., and Korn E.D. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 298 (1973) 1015-1019
8. Benttarari R.R., Amit T., and Youdim M. Binding of oestradiol, progesterone and prolactin in rat lung. J. Endocrinol. 97 (1983) 301-311
9. C'ocera M., Ĺopez O., and Coderch J.L. Alterations in stratum corneum lipid liposomes due to the action of Triton X-100: influence of the level of ceramides on this process. J. Control. Release 68 (2000) 387-396
10. Chauhan D., Li G., Hideshima T., Podar K., Mitsiades C., Mitsiades N., Munshi N., Kharbanda S., and Anderson K.C. JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J. Biol. Chem. 278 (2003) 17593-17596
11. Chong-Kook K., Mi-Kyung L., Jeong-Hee H., and Beom-Jin L. Pharmacokinetics and tissue distribution of methotrexate after intravenous injection of differently charged liposome-entrapped methotrexate to rats. Int. J. Pharm. 108 (1994) 21-29
12. D'Amato R.J., Lin C.M., Flynn E., Folkman J., and Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3964-3968
13. Dobos J., Timar J., Bocsi J., Burian Z., Nagy K., Barna G., Petak I., and Ladanyi A. In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int. J. Cancer 112 (2004) 771-776
14. Escuin D., Kline E.R., and Giannakakou P. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. Cancer Res. 65 (2005) 9021-9028
15. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5 (2005) 161-171
16. Gao S.H., Fan G.R., Hong Z.Y., Yin X.P., Yang S.L., and Wu Y.T. HPLC determination of polydatin in rat biological matrices: application to pharmacokinetic studies. J. Pharm. Biomed. Anal. 41 (2006) 240-245
17. Garcia G.E., Wisniewski H.G., Lucia M.S., Arevalo N., Slaga T.J., Kraft S.L., Strange R., and Kumar A.P. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6. Clin. Cancer Res. 12 (2006) 980-988
18. Glavas-Dodov M., Fredro-Kumbaradzi E., Goracinova K., Simonoska M., Calis S., Trajkovic-Jolevska S., and Hincal A.A. The effects of lyophilization on the stability of liposomes containing 5-FU. Int. J. Pharm. 291 (2005) 79-86
19. Gómez-Hens A., and Fernández-Romero J.M. Analytical methods for the control of liposomal delivery systems. Trends Anal. Chem. 25 (2006) 167-178
20. Huh J.I., Calvo A., Charles R., and Green J.E. Distinct tumor stagespecific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression. Cancer Res. 66 (2006) 3495-3503
21. Ireson C.R., Chander S.K., Purohit A., Perera S., Newman S.P., and Parish D. Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br. J. Cancer 90 (2004) 932-937
22. James J., Murry D.J., and Anthony M. Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer. Invest. New Drugs 25 (2006) 41-48
23. Kyung D.L., et al. Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim. Biophys. Acta: Biomembr. 1103 (1992) 185-197
24. Lu B. New Techniques and new Dosage forms of Drugs. 2nd ed. (2005), People's Medical Publishing House, Beijing
25. 2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3 (2003) 363-375
26. Mobed M., and Chang T.M. Comparison of polymerically stabilized PEG-grafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications. Biomaterials 19 (1998) 1167-1177
27. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and targetspecific nanoparticles: theory to practice. Pharmacol. Rev. 53 (2001) 283-318
28. Mooberry S.L. Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist. Update 6 (2003) 355-361
29. Mooberry S.L. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent. Curr. Opin. Oncol. 15 (2003) 425-430
30. Perttu S., Niemelä M.T., and Hyvönen I.V. Influence of chain length and unsaturation on sphingomyelin bilayers. Biophys. J. 90 (2006) 851-863
31. Raobaikady B., Purohit A., Chander S.K., Woo L.W., Leese M.P., Potter B.V., and Reed M.J. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate. J. Steroid Biochem. 84 (2003) 351-358
32. Santander-Ortega M.J., Jódar-Reyes A.B., Csaba N., Bastos-González D., and Ortega-Vinuesa J.L. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. J. Colloid Interf. Sci. 302 (2006) 522-529
33. Sato F., Fukuhara H., and Basilion J.P. Effects of hormone deprivation and 2-methoxyestradiol combination therapy on hormone-dependent prostate cancer in vivo. Neoplasia 7 (2005) 838-846
34. Shailendra S.R., and Prahlad C.G. Effect of surface charge and density of distearylphosphatidylethanolamine-mPEG-2000 (DSPE-mPEG-2000) on the cytotoxicity of liposome-entrapped ricin: effect of lysosomotropic agents. Int. J. Pharm. 350 (2008) 79-94
35. Sidor C., D'Amato R., and Miller K.D. The potential and suitability of 2-methoxyestradiol in cancer therapy. Clin. Cancer Res. 11 (2005) 6094-6095
36. Sun W.T., Zhang N., Li A., Zou W.W., and Xu W.F. Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int. J. Pharm. 353 (2008) 243-250
37. Sweeney C., Liu G., Yiannoutsos C., Kolesar J., Horvath D., and Staab M.J. A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, harmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Clin. Cancer Res. 11 (2005) 6625-6633
38. Zhang L.J., Xing B., Wu J., Xu B., and Fang X.L. Biodistribution in mice and severith of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes. Pulm. Pharmacol. Ther. 21 (2008) 239-246